Shares of Stericycle (SRCL) - Get Report were higher by 2.14% to $83.01 on Thursday morning, after the business-to-business service provider was started with an "overweight" rating and $100 price target at Barclays.
The firm is expecting earnings to bottom this year and then reaccelerate next year through 2020. Barclays says the company is strongly positioned in the medical waste sector.
"In our view, the market has now fully digested SRCL's challenges and lower expected revenue growth. We expect management focus in 2017 to be on putting to bed these legacy issues and reducing leverage to increase financial flexibility," Barclays said in a note, according to Barron's.
(What will move markets this quarter and how should investors position themselves ahead of time? Jim Cramer sat down with four of TheStreet's top columnists recently to get their views. Click here to listen to his latest Trading Strategies roundtable with them and read their advice for stocks, bonds, forex and gold.)